Not available
Quote | Clearside Biomedical Inc. (NASDAQ:CLSD)
Last: | $1.31 |
---|---|
Change Percent: | 0.76% |
Open: | $1.3 |
Close: | $1.31 |
High: | $1.34 |
Low: | $1.3 |
Volume: | 209,159 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | Clearside Biomedical Inc. (NASDAQ:CLSD)
2024-05-09 21:14:07 ET Clearside Biomedical, Inc. (CLSD) Q1 2024 Earnings Conference Call May 09, 2024 4:30 PM ET Company Participants Remy Bernarda - Investor Relations George Lasezkay - Chief Executive Officer Victor Chong - Chief Medical Officer Charlie De...
2024-05-09 16:52:18 ET More on Clearside Biomedical Clearside Biomedical, Inc. (CLSD) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Clearside Biomedical Historical earnings data for Clearside Biomedical Financial information for Clea...
Message Board Posts | Clearside Biomedical Inc. (NASDAQ:CLSD)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $CLSD 26% v2,3M C1.35 f61,364M H1.48 ML.9 RL1.03 | znewcar1 | investorshangout | 04/04/2023 8:26:00 PM |
Here we go | heyitsmeagain | investorshub | 08/10/2022 6:31:55 PM |
Loaded for this runner. Wish I had more loot. | heyitsmeagain | investorshub | 08/10/2022 5:38:09 PM |
Hard to Borrow is back on $CLSD today | BBANBOB | investorshub | 04/20/2022 1:29:09 PM |
FYI THE HARD TO BORROW classification(at Schwab) just went | BBANBOB | investorshub | 04/19/2022 2:23:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Clearside Biomedical Inc. Company Name:
CLSD Stock Symbol:
NASDAQ Market:
Clearside Biomedical Inc. Website:
The Dow Jones index closed higher by around 350 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concer...
- Phase 2b ODYSSEY Trial in Wet AMD Remains on Track with Topline Data Expected Q3 2024 - - Strengthened Management Team and Board of Directors with Two Key Additions - - Management to Host Webcast and Conference Call Today at 4:30 P.M. ET - ALPHARETTA, Ga., May 09, 2024 (GL...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...